These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3108615

  • 1. Noninvasive evaluation of effects of an aldose reductase inhibitor in rat brain by 19F FDG NMR spectroscopy.
    Nakada T, Kwee IL.
    Magn Reson Med; 1987 Apr; 4(4):366-71. PubMed ID: 3108615
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive demonstration of in vivo 3-fluoro-3-deoxy-D-glucose metabolism in rat brain by 19F nuclear magnetic resonance spectroscopy: suitable probe for monitoring cerebral aldose reductase activities.
    Kwee IL, Nakada T, Card PJ.
    J Neurochem; 1987 Aug; 49(2):428-33. PubMed ID: 3110372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noninvasive analysis of aldose reductase activities in rat testis: 3-FDG NMR spectroscopy and imaging.
    Nakada T, Kwee IL.
    Magn Reson Med; 1993 Apr; 29(4):543-5. PubMed ID: 8464370
    [Abstract] [Full Text] [Related]

  • 9. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK, Hanwell MA, Satchell PM, Turtle JR.
    Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
    [Abstract] [Full Text] [Related]

  • 10. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy.
    Williams WF, Odom JD.
    Science; 1986 Jul 11; 233(4760):223-5. PubMed ID: 3088727
    [Abstract] [Full Text] [Related]

  • 11. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
    Gonzalez AM, Sochor M, McLean P.
    Diabetes; 1983 May 11; 32(5):482-5. PubMed ID: 6404681
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM, Schofield PJ, Edwards MR.
    J Neurochem; 1982 Sep 11; 39(3):810-4. PubMed ID: 6808090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct 11; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
    Ares JJ, Kador PF, Miller DD.
    J Med Chem; 1986 Nov 11; 29(11):2384-9. PubMed ID: 3097318
    [Abstract] [Full Text] [Related]

  • 18. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
    Yeh LA, Rafford CE, Beyer TA, Hutson NJ.
    Metabolism; 1986 Apr 11; 35(4 Suppl 1):4-9. PubMed ID: 3083208
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 11; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.